A Tailored Approach to Minority Tobacco Cessation Programs

Researchers work with African American and American Indian communities to identify effective tobacco cessation strategies
24-Sep-2018 2:05 PM EDT Add to Favorites

Moving Homegrown Ideas into the Clinic

Physician-scientists at The University of Kansas Cancer center are designing and initiating their own clinical trials.
20-Sep-2018 11:05 AM EDT Add to Favorites

Researcher Investigates Eliminating Radiation for HER2-Positive Breast Cancer

Researchers at The University of Kansas Cancer Center have launched a clinical trial that eliminates radiation from the treatment protocol for an invasive type of breast cancer that accounts for one-fifth of all breast cancer patients.
29-Jun-2018 11:05 AM EDT Add to Favorites

Researchers Evaluate Methods for Quitting Tobacco

Researchers at The University of Kansas Cancer Center have received a five-year National Institutes of Health R0-1 grant to compare and evaluate the efficacy of optimized versus non-optimized tobacco cessation approaches for African American smokers.
26-Jun-2018 4:35 PM EDT Add to Favorites

New Drug Combination Shows Promise in Treating Ovarian Cancer

Researchers at The University of Kansas Cancer Center have discovered a therapy combination that may be helpful in the treatment of certain types of ovarian cancer.
7-Jun-2018 4:00 PM EDT Add to Favorites

The University of Kansas Cancer Center is joining forces with the nation’s top cancer centers to advocate for more HPV vaccinations

The University of Kansas Cancer Center is joining forces with a host of the nation’s top cancer centers to focus the spotlight on eliminating human papillomavirus (HPV)-related cancers in the United States.
7-Jun-2018 2:05 PM EDT Add to Favorites

Anti-cancer agent Ciclopirox Prodrug’s first-in-human Clinical Trial to be presented at ASCO 2018

The University of Kansas Cancer Center will present preclinical evidence supporting Ciclopirox Prodrug (CPX-POM), an anti-cancer agent currently in Phase I clinical trials, at the American Society of Clinical Oncology (ASCO) annual meeting in...
1-Jun-2018 9:05 AM EDT Add to Favorites

KU Medical Center Receives FDA Clearance to Proceed with Phase 1 Trial in Graft-versus-Host Disease Patients

The University of Kansas Medical Center announced that the U.S. Food and Drug Administration (FDA) has cleared it to begin a first-in-human clinical trial of MSCTC-0010 in patients with de novo high-risk acute or steroid-refractory acute...
16-May-2018 10:05 AM EDT Add to Favorites

see all news